跳至主要内容
临床试验/NCT01581931
NCT01581931已完成1 期

Bioequivalence of Metformin Under Fed Conditions After Administration of a 2.5 mg Linagliptin / 500 mg Metformin Fixed Dose Combination Tablet Compared With Single Linagliptin 2.5 mg and Metformin 500 mg Tablets Administered Together in Healthy Male and Female Volunteers, (an Open-label, Randomised, Single Dose, Two-way Crossover, Phase I Trial)

Boehringer Ingelheim1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2012年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
32
试验地点
1
主要终点
Area Under Curve From 0 to tz Hours (AUC0-tz) of Metformin

研究概览

简要总结

To establish bioequivalence (BE) under fed conditions between metformin in linagliptin/metformin fixed dose combination tablet and metformin reference product administered in free combination togther with linagliptin

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Linagliptin and metformin

Experimental

single tablets

干预措施: Metformin (Drug)

Linagliptin/metformin

Experimental

fixed dose combination tablet (FDC)

干预措施: Linagliptin/metformin (Drug)

Linagliptin and metformin

Experimental

single tablets

干预措施: Linagliptin (Drug)

结局指标

主要结局

Area Under Curve From 0 to tz Hours (AUC0-tz) of Metformin

时间窗: 0:20, 0:40, 1, 1:30, 2, 3, 4, 5, 6, 8, 12, 24, 34, 48, 72 hours

AUC0-tz represents the area under the concentration curve of metformin in plasma from 0 to the time of the last quantifiable plasma contentration of the analyte. Note, the geometric mean is actually an adjusted geometric mean.

Maximum Concentration (Cmax) of Metformin

时间窗: 0:20, 0:40, 1, 1:30, 2, 3, 4, 5, 6, 8, 12, 24, 34, 48, 72 hours

Cmax represents the maximum concentration of metformin in plasma. Note, the geometric mean is actually an adjusted geometric mean.

次要结局

  • Area Under Curve From 0 to Infinity Hours (AUC0-infty) of Metformin(0:20, 0:40, 1, 1:30, 2, 3, 4, 5, 6, 8, 12, 24, 34, 48, 72 hours)
  • Time to Maximum Concentration (Tmax) of Metformin(0:20, 0:40, 1, 1:30, 2, 3, 4, 5, 6, 8, 12, 24, 34, 48, 72 hours)
  • Terminal Half-life t1/2 of Metformin(0:20, 0:40, 1, 1:30, 2, 3, 4, 5, 6, 8, 12, 24, 34, 48, 72 hours)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Bioequivalence of Metformin Under Fed Conditions... | 临床试验